Latest News about MRK
Recent news which mentions MRK
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
April 04, 2023
From Benzinga
After Denying Earlier, Pfizer & Merck Marginally Cut Prices For COVID-19 Treatments In China
April 04, 2023
From Benzinga
From Benzinga
OncoSec Shares Disappointing Results From Skin Cancer Combo Therapy Trial, Sets Stage For Neoadjuvant Setting Study
April 03, 2023
From Benzinga
Twitter's Revenue Drops As Advertisers Voice Major Concerns
April 01, 2023
From Benzinga
From Benzinga
From Benzinga
From MarketWatch
From Motley Fool
From Motley Fool
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
From Benzinga
From InvestorPlace
Is the Best-Performing Dow Stock of the Past Year a Buy?
March 21, 2023
Tickers
MRK
From Motley Fool
7 Defensive Stocks to Buy During This Chaotic Spell
March 20, 2023
From InvestorPlace
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
From Benzinga
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 16, 2023
From Benzinga
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
March 14, 2023
From Benzinga
From Benzinga
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
March 13, 2023
From Benzinga
Merck's Keytuda+Chemo Combo Improves Overall Survival In Patients With Advanced Mesothelioma
March 10, 2023
Tickers
MRK
From Benzinga
From Benzinga
Why OPKO Health Shares Jumped on Wednesday
March 08, 2023
From Motley Fool
Dividend Stocks Alert: 10 Top Holdings From the SCHD ETF
March 08, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
